AtriCure News

Analysts Offer Insights on Healthcare Companies: Atricure (ATRC) and Sight Sciences (SGHT)

TipRanksApr 10 05:40 ET

AtriCure Analyst Ratings

BenzingaApr 10 05:31 ET

UBS Adjusts AtriCure Price Target to $58 From $57, Maintains Buy Rating

MT NewswiresFeb 16 10:55 ET

Oppenheimer Sticks to Its Hold Rating for Atricure (ATRC)

TipRanksFeb 16 07:57 ET

Analysts Offer Insights on Healthcare Companies: Atricure (ATRC), Charles River Labs (CRL) and Shockwave Medical (SWAV)

TipRanksFeb 16 07:20 ET

Atricure's Strong Performance and Growth Potential Merit a Buy Rating

TipRanksFeb 16 05:55 ET

AtriCure Analyst Ratings

BenzingaFeb 16 05:40 ET

UBS Adjusts AtriCure Price Target to $57 From $56, Maintains Buy Rating

MT NewswiresJan 22 11:38 ET

AtriCure's Growth Trajectory: A Strong Buy Rating With Revenue Surge and Strategic Expansions

TipRanksJan 9 07:47 ET

Atricure's Strong Growth and Positive Outlook Justify Buy Rating

TipRanksJan 8 13:25 ET

Analysts Offer Insights on Healthcare Companies: Atricure (ATRC), Ascendis Pharma (ASND) and G1 Therapeutics (GTHX)

TipRanksJan 8 10:10 ET

Analysts Offer Insights on Healthcare Companies: Xtant Medical Holdings (XTNT), Apollo Medical Holdings (AMEH) and Atricure (ATRC)

TipRanksJan 7 05:50 ET

Analysts Offer Insights on Healthcare Companies: Atricure (ATRC) and AbbVie (ABBV)

TipRanksJan 4 06:40 ET

Needham Maintains Buy on AtriCure, Lowers Price Target to $44

BenzingaJan 4 06:27 ET

AtriCure Analyst Ratings

BenzingaJan 4 06:26 ET

Atricure (ATRC) Gets a Buy From BTIG

TipRanksJan 2 09:07 ET

Analysts Offer Insights on Healthcare Companies: Atricure (ATRC) and Akoya Biosciences (AKYA)

TipRanksDec 21, 2023 08:40 ET

Analysts Offer Insights on Healthcare Companies: Altimmune (ALT) and Atricure (ATRC)

TipRanksDec 4, 2023 07:40 ET

Oppenheimer Keeps Their Hold Rating on Atricure (ATRC)

TipRanksDec 1, 2023 07:56 ET

AtriCure's Market Resilience and Growth Potential Warrant a Buy Rating

TipRanksDec 1, 2023 05:46 ET